检索

标题
作者
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V., Shamkhalova M., Duganova A.
Hyperuricemia and kidney damage in patients with cardiovascular disease: A review
Mironova O.
The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media
Vasin A., Mironova O., Fomin V.
Cardiorenal syndromes: historical aspects and current challenges
Nezhdanov K., Milovanova L., Strizhakov L., Krasnova T.
Herpesviruses in patients after renal transplantation
Dzhumabaeva B., Tikhomirov D., Biryukova L., Tupoleva T., Nesterenko I., Purlo N., Chebotarev D.
Chronic kidney disease and chronic heart failure: impact on prognosis and choice of pathogenetic therapy
Mezhonov E., Reitblat O., Vyalkina Y., Airapetian A., Lazareva N., Ageev F., Blankova Z., Svirida O., Prints Y., Zhirov I., Tereshchenko S., Boytsov S.
End products of glycation (AGEs) and inflammation in the clinic of cardiovascular complications and vascular calcification at different stages of chronic kidney disease (G1–G5D)
Fatima D., Remizov O., Ikoeva Z., Tedeeva I., Gusalov A., Goloeva V.
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Dzgoeva F., Remizov O., Goloeva V., Ikoeva Z.
Urinary biomarkers of kidney injury in patients treated with anti-VEGF drugs
Grechukhina K., Chebotareva N., Zhukova L., Androsova T., Karpov V., Krasnova T.
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
Kotenko O., Abolyan L., Kuteinikov V., Vinogradov V., Fomin V.
Frailty and chronic kidney disease – the real problem of modern nephrology: A review
Rudenko T., Bobkova I., Kamyshova E., Stavrovskaya E.
Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus
Murkamilov I., Aitbaev K., Fomin V.
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G., Lopatin Y., Ametov A., Ageev F., Antsiferov M., Villevalde S., Vinogradova N., Galstyan G., Galyavich A., Gilyarevskiy S., Glezer M., Zhirov I., Ilyin M., Lebedeva A., Nedogoda S., Salukhov V., Tarlovskaya E., Tereshchenko S., Fomin I., Khalimov I., Khasanov N., Cherkashin D., Yakushin S.
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Dzgoeva F., Remizov O., Botcieva V., Goloeva V., Malakhova N., Ikoeva Z.
Kidney involvement in rare hereditary diseases
Moiseev S., Shilov E.
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study
Milovanova L., Taranova M., Volkov A., Milovanova S., Beketov V.
Risk factors of kidney injury in patients with COVID-19
Shchepalina A., Chebotareva N., Kitbalian A., Potapov P., Nartova A., Akulkina L., Brovko M., Sholomova V., Moiseev S.
State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review
Bulanov N., Moiseev S.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
Kidney damage caused by lead exposure: historical aspects
Arkhipov E., Garipova R., Strizhakov L., Bobkova I., Tairova N.
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
Zubkin M., Frolova N., Kim I., Ushakova A., Usatiuk S., Iskhakov R., Diakova E., Chervinko V., Volodina E., Tomilina N., Kryukov E.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O., Martynov A., Arutyunov G., Bakulin I., Livzan M., Maev I., Egorov I.
Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis
Markina M., Milovanova L., Lysenko L., Milovanova S., Volkov A., Beketov V., Lebedeva M., Nezhdanov K., Moiseev S.
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
Shamkhalova M., Sukhareva O., Shestakova M.
Clinical and morphological correlations in patients with lupus nephritis: a retrospective study
Kurginian K., Stoliarevich E., Litvinova M., Kokhanchuk V., Shevchenko S., Pugach V., Novikov P., Moiseev S., Bulanov N.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Venous thromboembolic complications in patients with chronic kidney disease: prevalence and features of drug treatment
Dzhioeva O., Orlova A., Rogozhkina E., Drapkina O.
Idiopathic membranous nephropathy with focal segmental sclerosis
Kamyshova E., Bobkova I., Kakhsurueva P., Abdulaeva A., Rudenko T., Stavrovskaya E., Andreeva E., Li O., Suvorov A.
Contrast-induced acute kidney injury in chronic coronary artery disease patients with diabetes mellitus and obesity
Mironova O., Staroverov I., Sivakova O., Deev A., Fomin V.
Current challenges for therapy of comorbid patients: a new look at celecoxib. A review
Zyryanov S., Baybulatova E.
Anemia as a risk factor of contrast-associated acute kidney injury
Mironova O., Deev A., Lakotka P., Fomin V.
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E., Dudnikova A.
Contrast-induced acute kidney injury in patients with stable coronary artery disease: the most important risk factors and prevalence
Mironova O., Staroverov I., Sivakova O., Fomin V.
The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction
Karetnikova V., Kalaeva V., Evseeva M., Osokina A., Kashtalap V., Gruzdeva O., Shafranskaya K., Zykov M., Barbarash O.
Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
Chebotareva N., Gulyaev S., Androsova T., Popova E., Gurova D., Novikov P., Milovanova L., Moiseev S.
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
Bobkova I.
Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease
Demyanova K., Kozlovskaya N., Korotchaeva Y., Apresyan S., Rylceva L., Usatenko G., Lugovoj A., Vorobyeva M., Bondarenko T., Bespalova A., Volkova O.
Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment
Smirnov A., Afanasyev B., Poddubnaya I., Dobronravov V., Khrabrova M., Zakharova E., Nikitin E., Lysenko (Kozlovskaya) L., Bobkova I., Rameev V., Batyushin M., Moiseev I., Darskaya E., Pirogova O., Mendeleeva L., Biryukova L.
What we do and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman’s Day
Piccoli G., Alrukhaimi M., Zhi-Hong L., Zakharova E., Levin A.
Biomarkers of acute kidney injury: Current views and prospects
Kobalava Z., Villeval'de S., Efremovtseva M., Moiseev V.
Evaluation of markers for renal graft dysfunction in patients with type 1 diabetes mellitus after kidney transplantation and simultaneous pancreas-kidney transplantation
Glazunova A., Arutyunova M., Tarasov E., Nikankina L., Ilyin A., Shamkhalova M., Shestakova M., Moysyuk Y.
Resistant cytomegalovirus infection in related donor kidney allograft recipients
Goryainov V., Kaabak M., Babenko N., Platova E., Aganesov A., Morozova M., Panin V.
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
Mukhin N., Milovanov Y., Kozlovskaya L., Dobrosmyslov I., Milovanova L.
Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease
Dzgoeva F., Sopoev M., Gatagonova T., Bestaeva T., Khamitsaeva O.
Acute glomerulonephritis in the 21st century
Mukhin N., Glybochko P., Svistunov A., Fomin V., Shilov E., Lysenko L.
Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
Dzgoeva F., Gatagonova T., Bestaeva T., Sopoev M., Bazaeva B., Khamitsaeva O.
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
Pulin A., Kustova T., Fomin V., Mukhin N.
Efficiency and safety of lipid-lowering therapy for chronic kidney disease
Kolina I., Stavrovskaia E.
The pathogenetic bases of cardiorenal syndrome
Beloglazova I., Mogutova P., Poteshkina N.
1 - 50 的 171 信息 1 2 3 4 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##